OPER


main product lines are: ·The company's main areas of production are raw materials (monoclonal antibodies and recombinant antigens), immunochromatography - rapid tests, molecular diagnostics.
OPERON was established 1973 as a private R&D laboratory in the field of immunochemistry. At the beginning the Company's target was to satisfy the needs of the Spanish market. The initial products were immuno-plates, polyclonal antibodies labelled with peroxidase and fluorescein and agglutination latex products. In 1983 OPERON started its international sales operation. In 1986 the research of monoclonal antibodies was iniciated. And the first rapid tests was produced and sold in 1991. Since then new products are developed every year. The expresion of recombinant antigens were started in 2002. Two new product lines were launched in 2006: ready-to-use ELISA and Molecular Diagnostic kits manufacturing. Nowadays, the company is exporting to 50 countries all over the world.
Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |
OPERCamino del Plano, 19 |
Share with friends:
Next companies in category
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2025 Nanotechnology research | All rights reserved | Developed by Makovic.net